Andreas E. Kulozik

36.0k citations

230 papers · 10.2k indexed · 1 hit paper · h-index 54

Impact in

Genetics top 0.2%
- Glioma Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
Hematology top 0.5%
- Iron Metabolism and Disorders

Papers in

Genetics 75
- Hemoglobinopathies and Related Disorders 53
- Glioma Diagnosis and Treatment 14
Hematology 58
- Iron Metabolism and Disorders 28

Co-authors: Matthias W. Hentze Niels H. Gehring Gabriele Neu‐Yilik Martina U. Muckenthaler Sven Danckwardt Joachim B. Kunz Jill Holbrook Stephen Breit
Journals: Blood (28 papers)British Journal of Haematology (12 papers)Nucleic Acids Research (7 papers)Journal of Clinical Oncology (7 papers)RNA (5 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Andreas E. Kulozik

219 papers receiving 10.0k citations

Hit Papers

align trajectories log scale

A Perfect Message 1999 · 695 citations

Peers

Countries citing papers authored by Andreas E. Kulozik

Since Specialization

Citations

This map shows the geographic impact of Andreas E. Kulozik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas E. Kulozik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas E. Kulozik more than expected).

Fields of papers citing papers by Andreas E. Kulozik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas E. Kulozik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas E. Kulozik. The network helps show where Andreas E. Kulozik may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andreas E. Kulozik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas E. Kulozik Line = papers co-authored together Andreas E. Kulozik links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Betibeglogene Autotemcel (Beti-cel) Gene Addition Therapy Results in Durable Hemoglobin A (HbA) Production with up to 10 Years of Follow-up in Participants with Transfusion-Dependent β-Thalassemia Transplantation and Cellular Therapy ·Timothy S. Olson, Alexis A. Thompson, Janet L. Kwiatkowski, Jennifer Schneiderman, Isabelle Thuret, Andreas E. Kulozik, Evangelia Yannaki, Marina Cavazzana, Suradej Hongeng, Martin G. Sauer, Adrian J. Thrasher, Ashutosh Lal, John E.J. Rasko, Marvin Jesse, Tao Ge, Y. Yasu, Alberto Amutio Careaga, Mark C. Walters, Franco Locatelli	2025	0
2	Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group ( COSS ) Cancer Medicine ·Stefan Bielack, Írinan Barbosa de França, Daniel Baumhoer, Andreas Beilken, Claudia Blattmann, Godehard Friedel, Jendrik Hardes, Wolf Hassenpflug, Leo Kager, Matthias Kevric, Thekla von Kalle, Andreas E. Kulozik, Markus Metzler, Michaela Nathrath, Claudia Rössig, Benjamin Sorg, Sarvenaz Kashefi, Stefanie Hecker‐Nolting	2025	1
3	Origins of chromosome instability unveiled by coupled imaging and genomics Nature ·R. A. El- Desokey, 최윤진 김경근, Ana P. A. Silva, Álvaro Andrades, C. Fongher, Xvdong Yang, Michael Jendrusch, Sonia Zumalave, Tobias Rausch, Aliaksandr Halavatyi, Po-Shao Chen, Linda L Dearth-Monroe, Nur Hafizhah Binte Mohamad Rafi’ie, Patrick Hasenfeld, Eva Benito, Catherine Brasseur, Isidro Cortés‐Ciriano, Andreas E. Kulozik, Rainer Pepperkok, Jan O. Korbel	2025	0
4	Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma Nature Communications ·Yang Zhou, Partho Sarothi Ray, Jianguo Zhu, Frank Stein, Mandy Rettel, Vito Sciaraffia Palominos, Sudeep Sahadevan, Joel I. Perez-Perri, Firooz Haroon, Ola Myklebost, Leonardo A. Meza‐Zepeda, Andreas von Deimling, Chu‐Li Fu, M Dany-Mazeau, Kjetil Boye, Michaela Nathrath, Claudia Blattmann, Burkhard Lehner, Matthias W. Hentze, Andreas E. Kulozik	2024	5
5	Differential Analysis of the Nuclear and the Cytoplasmic RNA Interactomes in Living Cells Methods in molecular biology ·Michael Backlund, Andreas E. Kulozik	2022	2
6	Safety and Efficacy Outcomes in Pediatric Patients with Transfusion-Dependent β-Thalassemia (TDT) Receiving Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies Transplantation and Cellular Therapy ·Mark C. Walters, Janet L. Kwiatkowski, John B. Porter, Suradej Hongeng, Evangelia Yannaki, Andreas E. Kulozik, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Ruiting Guo, Weijian Liu, Richard A. Colvin, Franco Locatelli, Alexis A. Thompson	2021	1
7	Efficacy and Safety of Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in 60 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed for up to 6 Years Post-Infusion Transplantation and Cellular Therapy ·Suradej Hongeng, Alexis A. Thompson, Janet L. Kwiatkowski, Franco Locatelli, John B. Porter, John E.J. Rasko, Marina Cavazzana, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Andreas E. Kulozik, Evangelia Yannaki, Manfred Schmidt, Anouk C.M. Kuijpers, Ruiting Guo, Weijian Liu, Richard A. Colvin, Mark C. Walters	2021	1
8	Restoring Iron Homeostasis in Pts Who Achieved Transfusion Independence after Treatment with Betibeglogene Autotemcel Gene Therapy: Results from up to 7 Years of Follow-up Blood ·Alexis A. Thompson, Franco Locatelli, Evangelia Yannaki, Mark C. Walters, John B. Porter, Suradej Hongeng, Andreas E. Kulozik, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Marina Cavazzana, Arora Raman, Lin Du, Richard A. Colvin, Janet L. Kwiatkowski	2021	2
9	Plasticity of nuclear and cytoplasmic stress responses of RNA-binding proteins Nucleic Acids Research ·Michael Backlund, Frank Stein, Mandy Rettel, Thomas Schwarzl, Joel I. Perez-Perri, M Dany-Mazeau, Yang Zhou, Gabriele Neu‐Yilik, Matthias W. Hentze, Andreas E. Kulozik	2020	41
10	(Phospho)proteomic Profiling of Microsatellite Unstable CRC Cells Reveals Alterations in Nuclear Signaling and Cholesterol Metabolism Caused by Frameshift Mutation of NMD Regulator UPF3A International Journal of Molecular Sciences ·Malwina Michalak, Francisco Fabián Juárez Padilla, Darío Fros, Stefan M. Woerner, Luo Chao-li, Uwe Warnken, Yan P. Yuan, Peer Bork, Gabriele Neu‐Yilik, Andreas E. Kulozik, Magnus von Knebel Doeberitz, Matthias Kloor, Jürgen Kopitz, Johannes Gebert	2020	2
11	Favorable Outcomes in Pediatric Patients in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies of Betibeglogene Autotemcel Gene Therapy for the Treatment of Transfusion-Dependent β-Thalassemia Blood ·Alexis A. Thompson, Janet L. Kwiatkowski, John B. Porter, Suradej Hongeng, Evangelia Yannaki, Andreas E. Kulozik, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Ruiting Guo, Weijian Liu, Richard A. Colvin, Mark C. Walters, Franco Locatelli	2020	7
12	Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocol BMJ Open ·Maria‐Luisa Schubert, Anita Schmitt, Leopold Sellner, Brigitte Neuber, Joachim B. Kunz, Patrick Wuchter, Alexander Kunz, Ulrike Gern, Birgit Michels, Susanne Hofmann, Angela Hückelhoven‐Krauss, Andreas E. Kulozik, Anthony D. Ho, Carsten Müller‐Tidow, Peter Dreger, Michael Schmitt	2019	33
13	Dual function of UPF3B in early and late translation termination The EMBO Journal ·Gabriele Neu‐Yilik, Etienne Raimondeau, Boris Eliseev, Lahari Yeramala, Beate Amthor, Aurélien Deniaud, Karine Huard, 秀樹尾崎, Matthias W. Hentze, Christiane Schaffitzel, Andreas E. Kulozik	2017	73
14	Gain-of-function mutations in interleukin-7 receptor-α ( IL7R ) in childhood acute lymphoblastic leukemias The Journal of Experimental Medicine ·Chen Shochat, Noa Tal, Obul Reddy Bandapalli, Chiara Palmi, Ithamar Ganmore, Geertruy te Kronnie, Gunnar Cario, Giovanni Cazzaniga, Andreas E. Kulozik, Martin Stanulla, Martin Schrappe, Andrea Biondi, Giuseppe Basso, Dani Bercovich, Martina U. Muckenthaler, Shai Izraeli	2011	233
15	Adult Medulloblastoma Comprises Three Major Molecular Variants Journal of Clinical Oncology ·Marc Remke, Thomas Hielscher, Paul A. Northcott, Hendrik Witt, Marina Ryzhova, Andrea Wittmann, Axel Benner, Andreas von Deimling, Wolfram Scheurlen, Arie Perry, Sidney Croul, Andreas E. Kulozik, Peter Lichter, Michael D. Taylor, Stefan M. Pfister, Andrey Korshunov	2011	160
16	Role of LIM and SH3 Protein 1 (LASP1) in the Metastatic Dissemination of Medulloblastoma Cancer Research ·Christopher Traenka, Marc Remke, Andrey Korshunov, Sebastian Bender, Thomas Hielscher, Paul A. Northcott, Hendrik Witt, Marina Ryzhova, Jörg Felsberg, Axel Benner, Isabel Eichner, Wolfram Scheurlen, Thomas G. P. Grünewald, Andreas von Deimling, Andreas E. Kulozik, Guido Reifenberger, Michael D. Taylor, Peter Lichter, Elke Butt, Stefan M. Pfister	2010	55
17	Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci Journal of Clinical Oncology ·Stefan M. Pfister, Marc Remke, Axel Benner, Frank Mendrzyk, Grischa Toedt, Jörg Felsberg, Andrea Wittmann, Frauke Devens, Nicolas U. Gerber, Stefan Joos, Andreas E. Kulozik, Guido Reifenberger, Stefan Rutkowski, Otmar D. Wiestler, Bernhard Radlwimmer, Wolfram Scheurlen, Peter Lichter, Andrey Korshunov	2009	198
18	Histone deacetylase inhibitor Helminthosporium carbonum (HC)‐toxin suppresses the malignant phenotype of neuroblastoma cells International Journal of Cancer ·Hedwig E. Deubzer, Volker Ehemann, Frank Westermann, Ralf Heinrich, Gunhild Mechtersheimer, Andreas E. Kulozik, Manfred Schwab, Olaf Witt	2007	38
19	Expression of Late Cell Cycle Genes and an Increased Proliferative Capacity Characterize Very Early Relapse of Childhood Acute Lymphoblastic Leukemia Clinical Cancer Research ·Renate Kirschner‐Schwabe, Claudio Lottaz, فؤاد خطاب, Peter Rhein, Leonid Karawajew, Cornelia Eckert, Arend von Stackelberg, Ute Ungethüm, Dennis Kostka, Andreas E. Kulozik, Wolfgang Ludwig, Günter Henze, Rainer Spang, Christian Hagemeier, Karl Seeger	2006	32
20	The frequency and origin of the sickle cell mutation in the district of Coruche/Portugal Human Genetics ·Carlos E. Monteiro, José Rueff, H Ben-Assouna, Bickford C.J., D. J. Weatherall, Andreas E. Kulozik	1989	17

About Andreas E. Kulozik

Andreas E. Kulozik is a scholar working on Genetics, Hematology, Molecular Biology, Internal Medicine and Public Health, Environmental and Occupational Health, having authored 230 papers that have together received 10.2k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (53 papers), RNA Research and Splicing (41 papers), RNA and protein synthesis mechanisms (38 papers), RNA modifications and cancer (31 papers), Acute Lymphoblastic Leukemia research (31 papers), Iron Metabolism and Disorders (28 papers), Glioma Diagnosis and Treatment (14 papers) and Histone Deacetylase Inhibitors Research (14 papers). The work is most often cited by research in Genetics (2.0k citations), Hematology (1.5k citations), Molecular Biology (6.4k citations), Cancer Research (1.0k citations) and Neurology (567 citations). Andreas E. Kulozik has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Matthias W. Hentze, Niels H. Gehring, Gabriele Neu‐Yilik, Martina U. Muckenthaler, Sven Danckwardt, Joachim B. Kunz, Jill Holbrook, Stephen Breit, Stefan M. Pfister and Thomas Schell. Their work appears in journals such as Blood, British Journal of Haematology, Nucleic Acids Research, Journal of Clinical Oncology and RNA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact